Publication:
Pulmonary Abscess due to Leflunomide Use in Rheumatoid Arthritis: A Case Report

dc.authorscopusid6602591787
dc.authorscopusid8700081000
dc.authorscopusid22333972200
dc.authorscopusid23090431500
dc.contributor.authorUlusoy, H.
dc.contributor.authorBilgici, A.
dc.contributor.authorKuru, O.
dc.contributor.authorÇelenk, Ç.
dc.date.accessioned2020-06-21T15:37:14Z
dc.date.available2020-06-21T15:37:14Z
dc.date.issued2005
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Ulusoy] Hasan, Department of Physical Medicine and Rehabilitation, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bilgici] Ayhan, Department of Physical Medicine and Rehabilitation, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kuru] Ömer, Department of Physical Medicine and Rehabilitation, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Çelenk] Çetin, Department of Radiology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractA 43-year-old woman had rheumatoid arthritis (RA) for 5 years and complained of fever, arthralgia/myalgia, and night sweating for a month. She had been receiving only leflunomide (20 mg/day) for 5 months. On admission, there was no evidence of active arthritis or vasculitic lesion. Laboratory evaluation showed an erythrocyte sedimentation rate of 145 mm/h and C-reactive protein of 160 mg/dl. All cultures were negative. Chest radiograph and computed tomography (CT) revealed a pulmonary abscess. Staphylococcus aureus multiplied in the culture of a purulent sample obtained from the abscess under ultrasonography. The leflunomide was stopped, and sultamicillin (IV 4×2 g/day) was started for a further 6 weeks. Four weeks later, the patient had completely recovered and CT showed significant improvement of the pulmonary abscess. Ten milligrams/day of prednisolone and 7.5 mg/week of methotrexate were started for RA treatment. The patient has been under control for 5 months without any further abscess or RA activation. © Springer-Verlag 2004.en_US
dc.identifier.doi10.1007/s00296-004-0493-6
dc.identifier.endpage142en_US
dc.identifier.issn0172-8172
dc.identifier.issue2en_US
dc.identifier.pmid15322813
dc.identifier.scopus2-s2.0-16344382778
dc.identifier.scopusqualityQ2
dc.identifier.startpage139en_US
dc.identifier.urihttps://doi.org/10.1007/s00296-004-0493-6
dc.identifier.volume25en_US
dc.identifier.wosWOS:000228062700013
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherSpringer Heidelbergen_US
dc.relation.ispartofRheumatology Internationalen_US
dc.relation.journalRheumatology Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInfectionen_US
dc.subjectLeflunomideen_US
dc.subjectPulmonary Abscessen_US
dc.subjectRheumatoid Arthritisen_US
dc.titlePulmonary Abscess due to Leflunomide Use in Rheumatoid Arthritis: A Case Reporten_US
dc.typeArticleen_US
dspace.entity.typePublication

Files